Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
PerPA2Temps
Psychological Levers of Commitment and Persistence in Physical Activity in People With Type 2 Diabetes. PerPA2Temps Study
1 other identifier
interventional
77
1 country
1
Brief Summary
Many programmes exist to enable patients to engage in physical activity, but it is clear that the objectives are often not achieved in terms of quality, quantity or intensity of practice. In this study, the aim is to find alternatives, assuming that strengthening patients' self-efficacy, meeting their basic needs and increasing their level of hope will have an impact on their motivation to practice, which in turn will have an impact on their actual practice. The aim is to develop and implement an innovative intervention programme and to identify the interactions between the variables that are assumed to predict engagement in practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus-type-2
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2021
CompletedFirst Submitted
Initial submission to the registry
November 9, 2022
CompletedFirst Posted
Study publicly available on registry
December 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedDecember 22, 2022
December 1, 2022
1.6 years
November 9, 2022
December 21, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in amount of physical activity assessed by the French Version of GPAQ
The evolution of the quantity of physical activity will be the main criterion of judgment. It will be measured by the Global Physical Activity Questionnaire, which will allow for differentiation of intensities and contexts of practice. This questionnaire will be administered at each evaluation time proposed by the study (before/after, at 3, 6 and 12 months). The higher the score (in Metabolic Equivalent of Task/minutes/weeks), the greater the amount and intensity of physical activity performed. The comparison between the pre- and post-programme assessments (e.g. T0 and T1) will allow the direct effect of the programme on the amount of physical activity to be determined. The other assessments (e.g. T2, T3 and T4) will determine the persistence of this practice over time.
Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention
Secondary Outcomes (12)
Change in the subjects' motivational profile towards a more self-determined motivation assessed by the French Version of the Motivation for Physical Activity for Health Scale
Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention
Change in the satisfaction of basic psychological needs assessed by the French Version of The Basic Psychological Needs.
Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention
Change in self-efficacy assessed by the French Version of The Self-Efficacy Questionnaire
Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention
Change of initial state hope level assessed by the French Version of the State Hope Scale
Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention
Change in dispositional hope level assessed by the French Version of the Adult Dispositional Hope Scale
Pre-intervention/immediately after the intervention
- +7 more secondary outcomes
Study Arms (2)
Intervention Group
EXPERIMENTALThe proposed intervention consists of one hour of adapted physical activity per week for 12 weeks, led by a professional. In addition to this intervention, the intervention includes two 15-minute sessions, one before and one after the session. At the end of each session, a PA challenge and a positive reinforcement exercise will be proposed. The participants will have a week to try to achieve these. In addition to these two 15-minute sessions, participants will benefit from a one-and-a-half hour group session for information and experience sharing. The aim of this session is to discuss different topics related to diabetes.
Control group
ACTIVE COMPARATORThe proposed intervention consists of one hour of adapted physical activity per week for 12 weeks, led by a professional.
Interventions
The programme is a PA programme consisting of one weekly session for 12 weeks. The one hour of PA is supplemented by two 15-minute periods. At the end of each session, a PA challenge and a positive reinforcement exercise are proposed for the coming week. At the beginning of the next session, the facilitator has a dedicated time to give feedback on these challenges (successes and difficulties encountered). At the end of each session, the facilitator explains the theme of the next challenge and exercise. For the challenge, three options are proposed. Each participant chooses the option he/she prefers. Positive reinforcement exercises are also offered in the same way. They aim to strengthen motivation, hope and the sense of self-efficacy (SEP). In addition to these two 15-minute sessions, participants are offered a one-and-a-half hour group session for information and experience sharing. The aim of this session is to discuss different themes.
The programme is a PA programme consisting of one weekly session for 12 weeks.
Eligibility Criteria
You may qualify if:
- Subject over 18 years of age
- Subject who has given signed consent to participate in the protocol
- Type 2 diabetic subject not treated with insulin
- Subject participating for the first time in adapted physical activity sessions provided by Siel Bleu
- Subject understanding and reading French
You may not qualify if:
- Subjects with major health problems that prevent them from continuing the programme.
- Subjects who have withdrawn their consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Siel Bleulead
Study Sites (1)
Elise Maudet-Coulomb
Angers, Maine Et Loire, 49000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elise Maudet-Coulomb, Ms
Université de Lorraine, EA 4360 APEMAC, Metz, France
- STUDY CHAIR
Charles Martin-Krumm, PhD
Université de Lorraine, EA 4360 APEMAC, Metz, France
- STUDY CHAIR
Jean-Christophe Mino, PhD
Institut de recherche Siel Bleu, Paris France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2022
First Posted
December 22, 2022
Study Start
September 9, 2021
Primary Completion
April 1, 2023
Study Completion
April 1, 2023
Last Updated
December 22, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share